Case Study
Actionable results to inform your treatment decisions
Use the PrismRA test to identify a patient’s likelihood of inadequate response to TNFi therapy, whenever the result can inform therapeutic selection and treatment decision-making. The PrismRA test may be ordered for patients who are naïve or exposed to targeted therapies.
Even patients with similar clinical presentations can vary widely in their likelihood of response to TNFi therapy. This below case study offers an example of two similar patients with rheumatoid arthritis (RA) whose providers administered the PrismRA test to help guide their treatment decisions.
Case Study
Two similar female patients are starting targeted therapy.
Case Study
Two similar female patients are starting targeted therapy.


Patient's PrismRA results and proposed treatment decisions